𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Study of Bevacizumab (BEV), Temozolomide (TMZ) and Hypofractionated Stereotactic Radiotherapy (HFSRT) for Newly Diagnosed Glioblastoma (GBM)

✍ Scribed by K. Beal; A. Omuro; S. Karimi; D. Correa; T.A. Chan; L.M. DeAngelis; Y. Yamada; L.E. Abrey; P.H. Gutin


Book ID
118456304
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
42 KB
Volume
81
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES